JPRN-UMIN000009508
Recruiting
未知
Prevention of TaT1 bladder cancer by BCG instillation: Induction alone versus induction and maintenance - Randomized control study of prevention bladder cancer recurrence between BCG induction alone and BCG induction + maintenance
Department of Urology and Andrology, Kansai Medical university0 sites160 target enrollmentDecember 10, 2012
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Department of Urology and Andrology, Kansai Medical university
- Enrollment
- 160
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) first diagnosed Ta bladder cancer, and solitary, and less than 1cm, and urine cytology negative, and with CIS (carcinoma in situ) 2\) past history of BCG instillation 3\)1\) error correction Urine cytology positive after TUR\-Bt is excluded. pTa and solitary is excluded. With CIS is excluded.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
To investigate whether rinsing the bladder with chemotherapy right before an operation that removes the kidney and ureter because of a malignant tumor is effective to reduce the risk of a subsequent bladder tumorNL-OMON24959Erasmus university Medical Center170
Unknown
Not Applicable
Skipping BCG for T1a Urinary Bladder Tumor.Superficial Bladder Cancer t1aNCT04298073Assiut University43
Terminated
Not Applicable
Sequential Intravesical Bacillus Calmette-Guérin and Electromotive Mitomycin-C After Transuretheral ResectionBladder CarcinomaNCT02202044University of Colorado, Denver13
Active, not recruiting
Phase 1
Treatment Of Metastatic Bladder cancer at the time Of biochemical reLApse following radical cystectomy - TOMBOLArothelial cancerTherapeutic area: Diseases [C] - Male Urogenital Diseases [C12]Therapeutic area: Diseases [C] - Female Urogenital Diseases and Pregnancy Complications [C13]CTIS2024-510865-41-00Aarhus Universitetshospital282
Active, not recruiting
Not Applicable
TREATMENT OF NON-INVASIVE BLADDER CANCER WITH HIGH RISK OF RECURRENCE – BLUE LIGHT CYSTOSCOPY WITH CHEMOTHERAPYbladder cancer (non-invasive Ta urothelial bladder cancer)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2012-000559-15-FIFinnBladder